Committee for Medicinal Products for Human Use (chmp) Draft Guideline on Clinical Investigation of Medicinal Products for the Treatment of Juvenile Idiopathic Arthritis

COMMITTEE FOR MEDICINAL PRODUCTS FOR HUMAN USE (CHMP) DRAFT GUIDELINE ON MEDICINAL PRODUCTS FOR THE TREATMENT OF ALZHEIMER’S DISEASE AND OTHER DEMENTIAS DRAFT AGREED BY THE EFFICACY WORKING PARTY April – June 2007 ADOPTION BY CHMP FOR RELEASE FOR CONSULTATION

Committee for Medicinal Products for Human Use (chmp) Draft Guideline on the Evaluation of Anticancer Medicinal Products in Man

COMMITTEE FOR MEDICINAL PRODUCTS FOR HUMAN USE (CHMP) GUIDELINE ON THE CLINICAL INVESTIGATIONS OF MEDICINAL PRODUCTS FOR THE TREATMENT OF PULMONARY ARTERIAL HYPERTENSION AGREED BY EFFICACY WORKING PARTY November 2008 ADOPTION BY CHMP FOR RELEASE FOR CONSULTATION

Committee for Medicinal Products for Human Use (chmp) Guideline on the Investigation of Manufacturing Processes for Plasma-derived Medicinal Products with Regard to Vcjd Risk

Draft Guideline on clinical investigation of medicinal products for the treatment of acute heart failure (CHMP/EWP/2986/03 Rev 1)

7 This guideline replaces addendum CPMP/EWP/2986/03 " Note for guidance on clinical investigation of 8 medicinal products for the treatment of cardiac failure – addendum on acute cardiac failure ". 9 10 Comments should be provided using this template. The completed comments form should be sent to [email protected] 11 Keywords Acute heart failure, acute decompensated heart failure, ...